In the present study, we tested the hypotheses that CSF SNAP-25 levels and SNAP-25/Aβ42 ratio increase at every stage of AD and improve the diagnostic accuracy for AD compared with other core biomarkers. The gene discussed is SNAP25; the disease is Alzheimer disease.